
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
RASAL1 CRISPR/Cas9 KO Plasmid (m) | sc-422603 | 20 µg | $397.00 |
Rasal1 encodes RASAL1, a Ras GTPase-activating protein that accelerates the conversion of active Ras-GTP to inactive Ras-GDP, thereby restraining Ras-driven signaling. By modulating downstream RAF–MEK–ERK and PI3K–AKT pathway activity, RASAL1 influences cell proliferation, survival, and differentiation programs, including context-dependent effects on epithelial and mesenchymal phenotypes. Altered RASAL1 function or expression has been associated with dysregulated growth control and fibrotic remodeling in multiple tissues, supporting its relevance to studies of signaling homeostasis and disease-associated cellular reprogramming in mouse models. These properties make Rasal1 a useful node for dissecting Ras pathway feedback and cross-talk with transcriptional and extracellular matrix regulatory networks.
RASAL1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Rasal1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Rasal1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Rasal1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish RASAL1 protein expression.
This CRISPR knockout system enables efficient generation of Rasal1-deficient cell models for investigation of RASAL1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.